scholarly journals Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis

Author(s):  
Friederike Thomasius ◽  
Santiago Palacios ◽  
Asif Alam ◽  
Mitra Boolell ◽  
Francis Vekeman ◽  
...  
2021 ◽  
Vol 77 (18) ◽  
pp. 1639
Author(s):  
Alexander Hilt ◽  
Victor Umans ◽  
Tessel N.E. Vossenberg ◽  
Martin Schalij ◽  
Saskia Beeres

2018 ◽  
Vol 24 (2) ◽  
pp. 244-259
Author(s):  
Sepideh Eskandari Dorabati ◽  
Ali Zeinal Hamadani ◽  
Hamed Fazlollahtabar

Purpose Due to the fact that the non-standard products, being used by customers, may cause failures in products with sales delays, which naturally affect the warranty policy. Thus, it seems to be necessary to study these two concepts simultaneously. The paper aims to discuss these issues. Design/methodology/approach In this paper, a model is developed for estimating the expected warranty costs under sales delay conditions when two operator costs (failing but not reported and non-failing but reported) are included. Findings The proposed model is validated using a numerical example for a two types of intermittent and fatal failures occur under a non-renewing warranty policy. Originality/value Sales delay is the time interval between the date of production and the date of sale. Most reported literature on warranty claims data analysis related to sales delay have mainly focussed on estimating the probability distribution of the sales delay.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Stefan Scholz ◽  
Oliver Damm ◽  
Udo Schneider ◽  
Bernhard Ultsch ◽  
Ole Wichmann ◽  
...  

2009 ◽  
Vol 65 (10) ◽  
pp. 2077-2087 ◽  
Author(s):  
Andrea L. Murphy ◽  
Ruth Martin-Misener ◽  
Charmaine Cooke ◽  
Ingrid Sketris

2019 ◽  
Vol 57 (05) ◽  
pp. 574-583 ◽  
Author(s):  
Elena Georgiadou ◽  
Lena Fanter ◽  
Alina Brandes ◽  
Boris Ratsch ◽  
Heiko Friedel ◽  
...  

Abstract Introduction Perianal fistulas (PF) are presumably a frequent extraintestinal manifestation of Crohn’s disease (CD), causing significant functional impairment. This study aims to gain representative data on the prevalence, characteristics, and treatment of CD patients suffering from PF in Germany. Materials and methods A retrospective cross-sectional analysis of claims data from several German company health insurance funds included adult patients with CD and PF in 2015. The dataset comprised in- and outpatient services with diagnoses, drug prescriptions, and other patient data. It is representative for age, gender, and region and allows extrapolation to the total German statutory health insurance (SHI) population. A systematic literature review was conducted to discuss these results in the international context. Results A CD prevalence of 299 per 100 000 and a PF prevalence in CD patients of 3.4 % was observed in this cross-sectional study. PF are most prevalent in young age groups (< 24 to 39). One-third of patients with PF received biologics and surgery. Surgical procedures were performed in 31.3 % of PF patients in the inpatient setting and in 4.4 % of PF patients in the outpatient setting. All complicated perianal fistula patients received at least 1 inpatient surgery and 44.8 % received biologic therapy. Discussion This claims data analysis in German patients estimates a CD prevalence in the SHI population that corresponds well to previously reported data. The prevalence rate for PF in CD patients is comparable with a previous cross-sectional German claims data analysis but is markedly lower than cumulative risks reported in longitudinal cohort studies. PF patients are young and treatment intensive with one-third requiring biologic treatment or inpatient surgery.


Sign in / Sign up

Export Citation Format

Share Document